Nalaganje...

Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib

Follicular lymphoma is predominantly managed as a chronic disease, with intermittent chemo/immunotherapy reserved for symptomatic progression. It is considered incurable with conventional treatments, and current therapeutic options are associated with significant toxicities that are especially limit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Brander, Danielle M, Beaven, Anne W
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3333814/
https://ncbi.nlm.nih.gov/pubmed/22536060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S23241
Oznake: Označite
Brez oznak, prvi označite!